CRP and treatment resistant depression: As an exploratory aim, we will investigate whether TRD patients with evidence of abnormal inflammatory processes at baseline, are more likely to respond to minocycline, and whether changes in pro- and anti-inflammatory cytokines and C-reactive Protein (CRP) and natural log CRP (lnCRP) predict a response to minocycline.